packageTemozolomide

temozolomide

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Temozolomide is an alkylating anticancer drug used to treat brain cancers such as glioblastoma, anaplastic astrocytoma and other gliomas, as well as melanoma. It is an approved medicine with several authorised products in the European Union, where it is used for glioma and neuroblastoma, and it is also being investigated for other uses.

Summary written by glm-5.3-flash from Wikidata Q425088 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:temozolomide
ATC codes:L01AX03
DrugBank:DB00853
PubChem CID:5394
ChEBI:72564
Wikidata:Q425088
formula:C6H6N6O2
molar mass:194.154 g/mol (PubChem CID 5394)
logP:-1.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown